At the Society of Urologic Oncology Annual Meeting, Katie S. Murray, DO, NYU Grossman School of Medicine, and Christopher Wallis, MD, PhD, FRCSC, University of Toronto, discuss the nuances of chemoablation and renal preservation in upper tract urothelial carcinoma.
They highlight including optimal patient selection, size criteria, and how surgical ablation and chemoablation can fit together.